Bioemagno Pharmacological Clinical Unit has designed a blind placebo study approved by the ethics committee for review and regulatory approval by COFEPRIS. The Ion Gel ZCM-25 Clinical Phase 2 Human Dosing and Efficacy Study planned for the 4th quarter of 2021. The Mexican Government is partially funding the project.